The Types segmentation of the market captures the functional breadth of services offered by CDMOs, comprising Custom synthesis, Process development, Scale‑up production, and Analytical & regulatory support. Custom synthesis, which involves design‑to‑delivery of target molecules, contributes the largest share within the service mix, as clients increasingly outsource complex route scouting to reduce internal R&D burden. Process development, accounting for roughly one‑third of service spend, adds value by optimizing reaction conditions, yields, and safety profiles, directly influencing downstream cost structures. Scale‑up production, typically ranging from kilogram to metric‑ton batches, is essential for transitioning laboratory success to commercial viability and therefore commands premium pricing. Analytical & regulatory support, while smaller in absolute revenue, is indispensable for meeting GMP compliance and facilitating regulatory filings, thereby enabling market entry. Together, these service types define the market taxonomy of the Fine Chemicals CDMO sector, each segment reinforcing overall market growth through complementary capabilities.